+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cevimeline"

Sjogren's Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Sjogren's Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
From
Cevimeline Market in Canada - Product Thumbnail Image

Cevimeline Market in Canada

  • Report
  • March 2026
  • 153 Pages
  • Canada
From
Cevimeline Market in China - Product Thumbnail Image

Cevimeline Market in China

  • Report
  • March 2026
  • 162 Pages
  • China
From
Cevimeline Market in Germany - Product Thumbnail Image

Cevimeline Market in Germany

  • Report
  • March 2026
  • 154 Pages
  • Germany
From
Cevimeline Market in India - Product Thumbnail Image

Cevimeline Market in India

  • Report
  • March 2026
  • 155 Pages
  • India
From
From
From
  • 11 Results (Page 1 of 1)
Loading Indicator

Cevimeline is a drug used to treat immune disorders, such as Sjogren's Syndrome. It is a muscarinic agonist, meaning it stimulates the muscarinic receptors in the body, which helps to reduce inflammation and improve the body's ability to produce saliva and tears. Cevimeline is used to treat dry mouth and dry eyes, which are common symptoms of Sjogren's Syndrome. It is also used to treat other immune disorders, such as rheumatoid arthritis and lupus. Cevimeline is available in both oral and topical forms. The oral form is taken as a pill, while the topical form is applied directly to the affected area. The drug is generally well-tolerated, with few side effects. The Cevimeline market is composed of several companies that produce and distribute the drug. These companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Other companies, such as Pfizer and Merck, also produce generic versions of the drug. Show Less Read more